Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
HpARI (Alarmin Release Inhibitor) (rec.) (His)
360
CHF
CHF 360.00
In stock
AG-40B-0178-C05050 µgCHF 360.00
AG-40B-0178-30503 x 50 µgCHF 720.00
Figure 1: Binding of HpARI (Alarmin Release Inhibitor) (rec.) (His) (Prod. No. AG-40B-0178) to human and mouse IL-33.
Methods: IL-33 (human) (rec.) (untagged) (Prod. No. AG-40B-0038), IL-33 (mouse) (rec.) (untagged) (Prod. No. AG-40B-0041) as well as an unrelated control protein are coated on an ELISA plate at 1µg/ml. After blocking and washing steps, indicated concentrations of HpARI (Alarmin Release Inhibitor) (rec.) (His) are added. Following incubation for 1 h at RT, the binding was detected using an anti-His antibody (HRP).
Methods: IL-33 (human) (rec.) (untagged) (Prod. No. AG-40B-0038), IL-33 (mouse) (rec.) (untagged) (Prod. No. AG-40B-0041) as well as an unrelated control protein are coated on an ELISA plate at 1µg/ml. After blocking and washing steps, indicated concentrations of HpARI (Alarmin Release Inhibitor) (rec.) (His) are added. Following incubation for 1 h at RT, the binding was detected using an anti-His antibody (HRP).
Figure 2: Addition of HpARI (Alarmin Release Inhibitor) (rec.) (His) (Prod. No. AG-40B-0178) significantly reduces the effect of SW1116 colorectal cancer cells (CRC)-derived IL-33.
Method*: Groupe 2 Innate-lymphoid cells (ILC2s) are co-cultured with SW1116 CRC in RPMI medium. HpARI (Alarmin Release Inhibitor) (rec.) (His) (1µg/ml) is added or not in the medium for 24 hours. Frequencies of IL-13 positive ILC2s are measured by flow cytometry. Picture Courtesy of Giuseppe Ercolano, Camilla Jandus Lab, University of Geneva, Switzerland.
*For detailed method, see G, Ercolano, et al.; Nat. Comm. 12, 2538 (2021) [Lit. 3]
Method*: Groupe 2 Innate-lymphoid cells (ILC2s) are co-cultured with SW1116 CRC in RPMI medium. HpARI (Alarmin Release Inhibitor) (rec.) (His) (1µg/ml) is added or not in the medium for 24 hours. Frequencies of IL-13 positive ILC2s are measured by flow cytometry. Picture Courtesy of Giuseppe Ercolano, Camilla Jandus Lab, University of Geneva, Switzerland.
*For detailed method, see G, Ercolano, et al.; Nat. Comm. 12, 2538 (2021) [Lit. 3]
| Product Details | |
|---|---|
| Synonyms | Heligmosomoides Polygyrus Alarmin Release Inhibitor |
| Product Type | Protein |
| Properties | |
| Source/Host | HEK 293 cells |
| Sequence |
Heligmosomoides polygyrus protein HpARI (aa 17-251) is fused at the C-terminus to a His-tag. |
| Crossreactivity |
Human Mouse |
| Specificity |
Binds to human and mouse IL-33. |
| MW | ~40kDa (SDS-PAGE); ~40 kDa (Monomer) (SEC) |
| Purity | ≥90% (SDS-PAGE) |
| Endotoxin Content | <0.01EU/μg purified protein (LAL test). |
| Concentration | After reconstitution: 1mg/ml |
| Reconstitution | Reconstitute with 50μl sterile water. |
| Formulation | Lyophilized. Contains PBS. |
| Other Product Data |
Worm base HPBE_0000813301: Heligmosomoides polygyrus protein HpARI |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1% BSA should be used for further dilutions. |
| Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
HpARI is a protein secreted by the mouse parasite Heligmosomoides polygyrus. The mature protein HpARI, containing three predicted Complement Control Protein (CCP)-like modules (also known as Short Consensus Repeats (SCRs) or sushi-domains), suppresses type 2 (allergic) immune responses through interference in the interleukin-33 (IL-33) pathway. During cell damage, HpARI gains access to the nucleus of necrotic cells, where it binds directly to IL-33 and nuclear DNA, preventing secretion and binding of IL-33 to its receptor. HpARI is a new type of reagent to prevent IL-33-mediated pathology.
Product References
- An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor: M. Suzukawa, et al.; J. Immunol. 181, 5981 (2008)
- HpARI protein secreted by a helminth parasite suppresses interleukin-33: M. Osbourne, et al.; Immunity 47, 739 (2017)
- PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions: G. Ercolano, et al.; Nat. Commun. 12, 2538 (2021)
Related Products
